Results 1 to 10 of about 6,022 (84)

Advances in Radiopharmaceutical Sciences for Vascular Inflammation Imaging: Focus on Clinical Applications. [PDF]

Molecules, 2021
Biomedical imaging technologies offer identification of several anatomic and molecular features of disease pathogenesis. Molecular imaging techniques to assess cellular processes in vivo have been useful in advancing our understanding of several vascular inflammatory diseases.
Prigent K, Vigne J.
europepmc   +5 more sources

KSNM60: The History of Radiopharmaceutical Sciences in Korea. [PDF]

Nucl Med Mol Imaging, 2022
A number of researchers in Korea have tried to set-up the production of radionuclides and develop new radiopharmaceuticals for several decades. Thanks to their 60-year endeavor to advance the field of radiopharmaceutical sciences, now we have a lot of research units and facilities in Korea.
Yoo RJ, Lee YS, Lee KC, Kim DW, Kim DY, Choe YS, Jeong JM.   +6 more
europepmc   +3 more sources

Recent advances and impending challenges for the radiopharmaceutical sciences in oncology. [PDF]

Lancet Oncol
This paper is the first of a Series on theranostics that summarises the current landscape of the radiopharmaceutical sciences as they pertain to oncology. In this Series paper, we describe exciting developments in radiochemistry and the production of radionuclides, the development and translation of theranostics, and the application of artificial ...
Lapi SE, Scott PJH, Scott AM, Windhorst AD, Zeglis BM, Abdel-Wahab M, Baum RP, Buatti JM, Giammarile F, Kiess AP, Jalilian A, Knoll P, Korde A, Kunikowska J, Lee ST, Paez D, Urbain JL, Zhang J, Lewis JS.   +18 more
europepmc   +5 more sources

Trends in nuclear medicine and the radiopharmaceutical sciences in oncology: workforce challenges and training in the age of theranostics. [PDF]

Lancet Oncol
Although the promise of radionuclides for the diagnosis and treatment of disease was recognised soon after the discovery of radioactivity in the late 19th century, the systematic use of radionuclides in medicine only gradually increased over the subsequent hundred years.
Scott AM, Zeglis BM, Lapi SE, Scott PJH, Windhorst AD, Abdel-Wahab M, Giammarile F, Piaez D, Jalilian A, Knoll P, Korde A, Vichare S, Ayati N, Lee ST, Lyashchenko SK, Zhang J, Urbain JL, Lewis JS.   +17 more
europepmc   +3 more sources

Status of the 'consensus nomenclature rules in radiopharmaceutical sciences' initiative. [PDF]

Nucl Med Biol, 2019
Coenen HH, Gee AD, Adam M, Antoni G, Cutler CS, Fujibayashi Y, Jeong JM, Mach RH, Mindt TL, Pike VW, Windhorst AD.   +10 more
europepmc   +5 more sources

How green are radiopharmaceutical sciences? [PDF]

Nuclear Medicine and Biology
The rapid growth of radiopharmaceutical sciences, driven by regulatory approvals of theranostic agents and the expanding role of PET imaging, underscores the need for sustainable and green practices. While radiopharmaceuticals offer high precision and targeted therapy with minimal systemic toxicity, the field faces challenges related to increasing ...
Pichler, Verena, Herth, Matthias Manfred, Hugenberg, Verena, Scott, Peter J.H., Spreckelmeyer, Sarah, Stotz, Sophie, Pascali, Giancarlo   +6 more
openaire   +3 more sources

Nuclear medicine and imaging research (quantitative studies in radiopharmaceutical science) [PDF]

, 1990
This report describes three studies aimed at using radiolabeled pharmaceuticals to explore brain function and anatomy. The first section describes the chemical preparation of (F18)fluorinated benzamides (dopamine D-2 receptor tracers), (F18)fluorinated benzazepines (dopamine D-1 receptor tracers), and tissue distribution of (F18)-fluoxetine (serotonin ...
Cooper, M., Beck, R. N.
openaire   +2 more sources

Science research experience in the use of radiopharmaceuticals at the N.N. Petrov NMRC of Oncology [PDF]

Pharmacy Formulas, 2021
Radionuclide diagnostics and therapy with open radionuclide sources are one of the most promising and fast-growing areas ofmodern oncology. The paper presents the main achievements of the N.N. Petrov National Medical Research Center of Oncology, one of the leading departments of radionuclide diagnostics in Russia.
openaire   +1 more source

Installation of First Medium Energy Medical Cyclotron in Bangladesh at National Institute of Nuclear Medicine and Allied Sciences (NINMAS) for PET radiopharmaceuticals Production

Bangladesh Journal of Nuclear Medicine, 2022
PET-CT (positron emission tomography and computed tomography) is a gold-standard cancer imaging tool for diagnosis and management, as well as prognostic information based on treatment. Positron-emitting radionuclide 18F (Fluorine) is generated by accelerating particles to energies high enough to cause a certain nuclear reaction 18O(p,n)18F within the ...
Mohammad Anwar Ul Azim, Sanchoy Chandra Biswasarma, Jashim Uddin, Md Ariful Islam, Nahid Hossain, Md Shohag Mia, Hasan Mehdi, Md Alamgir Kabir, Mustafa Mamun, Ferdoushi Begum, Shamim Momtaz Ferdousi Begum, Md Nurul Islam   +11 more
openaire   +1 more source

Quantitative studies in radiopharmaceutical science

, 1989
The scientific direction of the work in this grant is unchanged and the 12 research projects in the three major categories represent only minor modification from the proposed work given at site visit. Adjustment was necessary in keeping with the award and to accommodate the resignation of Dr. S.
M. Cooper, R. Beck
openaire   +2 more sources